126 related articles for article (PubMed ID: 37317725)
1. Expression of Ber-EP4 and CD34 can distinguish clear-cell basal cell carcinoma from trichilemmoma: A case series.
Mitra A; Schulman JM
Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):118-120. PubMed ID: 37317725
[No Abstract] [Full Text] [Related]
2. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin.
Tellechea O; Reis JP; Domingues JC; Baptista AP
Am J Dermatopathol; 1993 Oct; 15(5):452-5. PubMed ID: 8238781
[TBL] [Abstract][Full Text] [Related]
3. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Ameloblastoma: A Study of 18 Cases and Usage of Ber-EP4 Immunohistochemistry to Rule out a Diagnosis of Intraoral Basal Cell Carcinoma.
Upadhyaya JD; Bhattacharyya I; Fitzpatrick SG; Cohen DM; Islam MN
J Oral Maxillofac Surg; 2018 May; 76(5):996-1004. PubMed ID: 29247621
[TBL] [Abstract][Full Text] [Related]
5. Utility of Ber-EP4 and MOC-31 in Basaloid Skin Tumor Detection.
Gill P; Naugler C; Abi Daoud MS
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):584-588. PubMed ID: 29629953
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
7. Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.
Tope WD; Nowfar-Rad M; Kist DA
Dermatol Surg; 2000 May; 26(5):415-8. PubMed ID: 10816226
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal.
Webb DV; Mentrikoski MJ; Verduin L; Brill LB; Wick MR
Ann Diagn Pathol; 2015 Apr; 19(2):70-5. PubMed ID: 25702956
[TBL] [Abstract][Full Text] [Related]
9. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
10. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
Beer TW; Shepherd P; Theaker JM
Histopathology; 2000 Sep; 37(3):218-23. PubMed ID: 10971697
[TBL] [Abstract][Full Text] [Related]
11. A unique basaloid proliferation encountered during Mohs surgery: potential pitfall for overdiagnosis of basal cell carcinoma.
Patel NS; Johnston RB; Messina JL; Cherpelis BS
Dermatol Surg; 2011 Aug; 37(8):1180-8. PubMed ID: 21668568
[No Abstract] [Full Text] [Related]
12. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma.
Illueca C; Monteagudo C; Revert A; Llombart-Bosch A
J Cutan Pathol; 1998 Sep; 25(8):435-9. PubMed ID: 9826169
[TBL] [Abstract][Full Text] [Related]
13. Trichoepithelioma Misdiagnosed as Basal Cell Carcinoma.
Kang KJ; Seo BF; Shin J; Kwon H; Byeon JH; Jung SN
J Craniofac Surg; 2019; 30(3):e197-e199. PubMed ID: 30394977
[TBL] [Abstract][Full Text] [Related]
14. Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation.
Kist D; Perkins W; Christ S; Zachary CB
Dermatol Surg; 1997 Nov; 23(11):1067-70. PubMed ID: 9391566
[TBL] [Abstract][Full Text] [Related]
15. Fibroepithelial tumor of pinkus is trichoblastic (Basal-cell) carcinoma.
Ackerman AB; Gottlieb GJ
Am J Dermatopathol; 2005 Apr; 27(2):155-9. PubMed ID: 15798443
[No Abstract] [Full Text] [Related]
16. Trichilemmoma.
Chan P; White SW; Pierson DL; Rodman OG
J Dermatol Surg Oncol; 1979 Jan; 5(1):58-9. PubMed ID: 759462
[TBL] [Abstract][Full Text] [Related]
17. Trichilemmoma of eyelid and eyebrow. A clinicopathologic study of 31 cases.
Hidayat AA; Font RL
Arch Ophthalmol; 1980 May; 98(5):844-7. PubMed ID: 6990903
[TBL] [Abstract][Full Text] [Related]
18. CD34 and BerEP4 Are Helpful to Distinguish Basaloid Tricholemmoma From Basal Cell Carcinoma.
Turnbull N; Ghumra W; Mudaliar V; Vella J; Sanders DSA; Taibjee S; Carr R
Am J Dermatopathol; 2018 Aug; 40(8):561-566. PubMed ID: 29570129
[TBL] [Abstract][Full Text] [Related]
19. Limitations of Ber-EP4 for distinction of Bowen disease from basal cell carcinoma.
Kogut M; Toberer F; Enk AH; Hassel JC
J Cutan Pathol; 2016 Apr; 43(4):367-71. PubMed ID: 26765054
[TBL] [Abstract][Full Text] [Related]
20. Rare desmoplastic trichilemmoma associated with sebaceous nevus.
Jardim MML; Souza BCE; Fraga RC; Fraga RC
An Bras Dermatol; 2017; 92(6):836-837. PubMed ID: 29364442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
